GMAB logo

Genmab A/S (GMAB) Free Cash Flow

Annual FCF

$1.08 B
+$66.49 M+6.54%

December 1, 2024


Summary


Performance

GMAB Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

Quarterly FCF

$353.01 M
+$51.48 M+17.07%

December 1, 2024


Summary


Performance

GMAB Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

TTM FCF

$1.08 B
+$124.56 M+12.99%

December 1, 2024


Summary


Performance

GMAB TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

GMAB Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.5%+17.1%+13.0%
3 y3 years+244.6%+17.1%+13.0%
5 y5 years+494.7%+17.1%+13.0%

GMAB Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+244.6%-21.8%+1135.4%at high+423.8%
5 y5-yearat high+494.7%-56.4%+323.1%-3.3%+748.7%
alltimeall timeat high+419.6%-56.4%+323.1%-3.3%+1005.8%

Genmab A/S Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
$1.08 B(+6.5%)
$353.01 M(+17.1%)
$1.08 B(+13.0%)
Sep 2024
-
$301.53 M(+41.9%)
$958.82 M(+2.0%)
Jun 2024
-
$212.55 M(-1.7%)
$940.04 M(+20.3%)
Mar 2024
-
$216.30 M(-5.3%)
$781.65 M(-23.1%)
Dec 2023
$1.02 B(+99.5%)
$228.45 M(-19.2%)
$1.02 B(+19.6%)
Sep 2023
-
$282.75 M(+422.1%)
$850.36 M(+4.7%)
Jun 2023
-
$54.16 M(-88.0%)
$811.89 M(-7.9%)
Mar 2023
-
$451.53 M(+629.2%)
$881.21 M(+72.9%)
Dec 2022
$509.63 M(+62.1%)
$61.92 M(-74.7%)
$509.63 M(+7.0%)
Sep 2022
-
$244.28 M(+97.8%)
$476.29 M(+66.8%)
Jun 2022
-
$123.48 M(+54.4%)
$285.62 M(+38.1%)
Mar 2022
-
$79.95 M(+179.8%)
$206.82 M(-34.2%)
Dec 2021
$314.42 M(-66.5%)
$28.57 M(-46.7%)
$314.42 M(+146.3%)
Sep 2021
-
$53.61 M(+20.0%)
$127.65 M(-85.5%)
Jun 2021
-
$44.68 M(-76.2%)
$882.89 M(+3.6%)
Mar 2021
-
$187.56 M(-218.6%)
$852.18 M(-9.2%)
Dec 2020
$938.63 M(+415.2%)
-$158.20 M(-119.6%)
$938.63 M(-16.2%)
Sep 2020
-
$808.85 M(+5688.5%)
$1.12 B(+219.6%)
Jun 2020
-
$13.97 M(-94.9%)
$350.40 M(-2.9%)
Mar 2020
-
$274.00 M(+1094.7%)
$360.76 M(+98.0%)
Dec 2019
$182.18 M(+114.2%)
$22.93 M(-41.9%)
$182.18 M(-3.7%)
Sep 2019
-
$39.49 M(+62.3%)
$189.09 M(+62.3%)
Jun 2019
-
$24.33 M(-74.5%)
$116.51 M(+7.2%)
Mar 2019
-
$95.42 M(+219.8%)
$108.68 M(+27.8%)
Dec 2018
$85.06 M(-62.7%)
$29.84 M(-190.2%)
$85.06 M(+2.9%)
Sep 2018
-
-$33.09 M(-300.5%)
$82.66 M(-36.9%)
Jun 2018
-
$16.50 M(-77.0%)
$130.91 M(-32.2%)
Mar 2018
-
$71.81 M(+161.8%)
$192.97 M(-15.5%)
Dec 2017
$228.32 M(+421.4%)
$27.43 M(+81.0%)
$228.32 M(+23.4%)
Sep 2017
-
$15.16 M(-80.7%)
$185.09 M(-7.5%)
Jun 2017
-
$78.56 M(-26.7%)
$200.03 M(+30.9%)
Mar 2017
-
$107.17 M(-778.1%)
$152.84 M(+249.0%)
Dec 2016
$43.79 M
-$15.80 M(-152.5%)
$43.79 M(-53.8%)
Sep 2016
-
$30.10 M(-4.1%)
$94.74 M(+11.9%)
Jun 2016
-
$31.37 M(-1765.6%)
$84.68 M(+137.3%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$1.88 M(-105.4%)
$35.69 M(+36.3%)
Dec 2015
$26.19 M(+156.6%)
$35.15 M(+75.4%)
$26.19 M(-436.7%)
Sep 2015
-
$20.04 M(-213.8%)
-$7.78 M(-67.0%)
Jun 2015
-
-$17.62 M(+54.8%)
-$23.54 M(-912.0%)
Mar 2015
-
-$11.38 M(-1068.1%)
$2.90 M(-71.6%)
Dec 2014
$10.21 M(-141.4%)
$1.18 M(-72.5%)
$10.21 M(+77.0%)
Sep 2014
-
$4.28 M(-51.5%)
$5.77 M(-171.6%)
Jun 2014
-
$8.82 M(-316.6%)
-$8.05 M(-62.5%)
Mar 2014
-
-$4.07 M(+24.7%)
-$21.44 M(-13.0%)
Dec 2013
-$24.64 M(-330.4%)
-$3.27 M(-65.7%)
-$24.64 M(-10.7%)
Sep 2013
-
-$9.53 M(+108.6%)
-$27.60 M(-212.4%)
Jun 2013
-
-$4.57 M(-37.2%)
$24.54 M(+56.6%)
Mar 2013
-
-$7.27 M(+16.8%)
$15.67 M(+46.5%)
Dec 2012
$10.69 M(-112.9%)
-$6.22 M(-114.6%)
$10.69 M(-352.6%)
Sep 2012
-
$42.61 M(-417.0%)
-$4.23 M(-93.6%)
Jun 2012
-
-$13.44 M(+9.8%)
-$66.41 M(-18.7%)
Mar 2012
-
-$12.25 M(-42.1%)
-$81.65 M(-1.6%)
Dec 2011
-$83.02 M(-280.7%)
-$21.15 M(+8.1%)
-$83.02 M(-3.4%)
Sep 2011
-
-$19.57 M(-31.8%)
-$85.93 M(-229.5%)
Jun 2011
-
-$28.69 M(+110.7%)
$66.34 M(-9.1%)
Mar 2011
-
-$13.62 M(-43.4%)
$72.97 M(+58.8%)
Dec 2010
$45.94 M(-141.8%)
-$24.06 M(-118.1%)
$45.94 M(-15.8%)
Sep 2010
-
$132.71 M(-701.6%)
$54.59 M(-145.6%)
Jun 2010
-
-$22.06 M(-45.7%)
-$119.60 M(+2.4%)
Mar 2010
-
-$40.64 M(+163.7%)
-$116.80 M(+6.3%)
Dec 2009
-$109.83 M(-67.6%)
-$15.41 M(-62.8%)
-$109.83 M(+16.3%)
Sep 2009
-
-$41.48 M(+115.4%)
-$94.41 M(+78.4%)
Jun 2009
-
-$19.26 M(-42.8%)
-$52.93 M(+57.2%)
Mar 2009
-
-$33.67 M
-$33.67 M
Dec 2008
-$338.97 M(-474.2%)
-
-
Dec 2007
$90.59 M(-241.0%)
-
-
Dec 2006
-$64.26 M(+82.3%)
-
-
Dec 2005
-$35.26 M(-43.9%)
-
-
Dec 2004
-$62.88 M(+30.3%)
-
-
Dec 2003
-$48.27 M(-7.3%)
-
-
Dec 2002
-$52.06 M
-
-

FAQ

  • What is Genmab A/S annual free cash flow?
  • What is the all time high annual FCF for Genmab A/S?
  • What is Genmab A/S annual FCF year-on-year change?
  • What is Genmab A/S quarterly free cash flow?
  • What is the all time high quarterly FCF for Genmab A/S?
  • What is Genmab A/S quarterly FCF year-on-year change?
  • What is Genmab A/S TTM free cash flow?
  • What is the all time high TTM FCF for Genmab A/S?
  • What is Genmab A/S TTM FCF year-on-year change?

What is Genmab A/S annual free cash flow?

The current annual FCF of GMAB is $1.08 B

What is the all time high annual FCF for Genmab A/S?

Genmab A/S all-time high annual free cash flow is $1.08 B

What is Genmab A/S annual FCF year-on-year change?

Over the past year, GMAB annual free cash flow has changed by +$66.49 M (+6.54%)

What is Genmab A/S quarterly free cash flow?

The current quarterly FCF of GMAB is $353.01 M

What is the all time high quarterly FCF for Genmab A/S?

Genmab A/S all-time high quarterly free cash flow is $808.85 M

What is Genmab A/S quarterly FCF year-on-year change?

Over the past year, GMAB quarterly free cash flow has changed by +$51.48 M (+17.07%)

What is Genmab A/S TTM free cash flow?

The current TTM FCF of GMAB is $1.08 B

What is the all time high TTM FCF for Genmab A/S?

Genmab A/S all-time high TTM free cash flow is $1.12 B

What is Genmab A/S TTM FCF year-on-year change?

Over the past year, GMAB TTM free cash flow has changed by +$124.56 M (+12.99%)